Antigonie Biosciences Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Antigonie Biosciences General Information
Description
Developer of a gene therapy platform designed to eliminate malignant blood-forming stem cells through selective mutation silencing. The company's platform targets specific mutations within hematopoietic stem cells while preserving healthy tissues, enabling researchers to transition patients from lifelong disease management to curative medical strategies.
Contact Information
Website
www.antigonie.bioCorporate Office
- Centre For Blood Research, University Of York
- York YO10 5DD
- England, United Kingdom
Corporate Office
- Centre For Blood Research, University Of York
- York YO10 5DD
- England, United Kingdom
Antigonie Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 08-Jun-2026 | Completed | Pre-Clinical Trials | |||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Antigonie Biosciences Signals
Antigonie Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pxn Ventures | Corporate Venture Capital | Minority | ||
| Cancer Tech Accelerator | Accelerator/Incubator |
Antigonie Biosciences FAQs
-
When was Antigonie Biosciences founded?
Antigonie Biosciences was founded in 2025.
-
Where is Antigonie Biosciences headquartered?
Antigonie Biosciences is headquartered in York, United Kingdom.
-
What is the size of Antigonie Biosciences?
Antigonie Biosciences has 3 total employees.
-
What industry is Antigonie Biosciences in?
Antigonie Biosciences’s primary industry is Drug Delivery.
-
Is Antigonie Biosciences a private or public company?
Antigonie Biosciences is a Private company.
-
What is Antigonie Biosciences’s current revenue?
The current revenue for Antigonie Biosciences is .
-
Who are Antigonie Biosciences’s investors?
Pxn Ventures and Cancer Tech Accelerator have invested in Antigonie Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process